Sunny Isles Beach, Florida, Miami, RK Centers mall, company indication, CVS Drug store retailer, pharmacy chain prescription medication. (Picture by: Jeffrey Greenberg/Universal Images Group by means of Getty Images)
Jeff Greenberg|Universal Images Group|Getty Images
The U.S. Federal Reserve cut crucial rate of interest by 25 basis points, reducing loaning expenses for the 3rd time in 2025. Provided the lower rate of interest background (which minimizes the appeal of fixed-income financial investments) and an unpredictable stock exchange, some financiers may wish to think about including dividend stocks to their portfolios to guarantee steady earnings and improve general returns.
The stock choices of leading Wall Street experts can assist financiers choose appealing dividend-paying business.
Here are 3 dividend-paying stocks, highlighted by Wall Street’s leading pros, as tracked by TipRanks, a platform that ranks experts based upon their previous efficiency.
Devon Energy
Today’s very first dividend choice is Devon Energy (DVN), an independent oil and gas expedition and production (E&P) business. In the 3rd quarter of 2025, Devon returned $401 million to investors through share repurchases and dividends. The business’s set quarterly dividend of $0.24 per share (annualized dividend of $0.96 per share) shows a yield of 2.5%.
Just Recently, JP Morgan expert Arun Jayaram updated Devon Energy stock to purchase from hold, though he decreased the rate target to $44 from $49. TipRanks’ AI Expert has an “outperform” ranking on DVN stock with a cost target of $43.
Jayaram discussed that his ranking upgrade was based upon DVN’s engaging assessment compared to its peers, supported by totally free capital gains from the business’s $1 billion company optimization strategy. The 5 star expert kept in mind that Devon accomplished about 60% of its $1 billion objective in a little over half a year following the strategy’s official rollout.
The expert kept in mind that Devon’s Delaware Basin well performance was negatively affected by the business’s concentrate on finishing a greater percentage of Wolfcamp B wells. That stated, Jayaram anticipates well performance to be steady in 2026 and 2027 due to a “steadier mix of secondary zones” compared to 2025.
In General, Jayaram is bullish on Devon, considered that it has a high-grade acreage position in the most vital parts of the Delaware Basin, Bakken, and Eagle Ford shale areas. Additionally, the business has the choice to broaden in the STACK and Powder River Basins.
” Our company believe DVN’s core franchise properties have the prospective to offer a big stock of lower-risk, high rate-of-return advancement drilling chances that are important provided the diminishing nature of an E&P’s property base,” stated Jayaram.
Jayaram ranks No. 655 amongst more than 10,100 experts tracked by TipRanks. His scores have actually paid 59% of the time, providing a typical return of 10.3%. See Devon Energy Data on TipRanks.
EOG Resources
The next dividend-paying stock is EOG Resources ( EOG), a petroleum and gas expedition and production business with reserves in the U.S. and Trinidad. In the 3rd quarter of 2025, EOG paid $545 million in routine dividends and bought shares worth $440 million. Last month, EOG revealed a quarterly dividend of $ 1.02 per share, payable on January 30, 2026. At an annualized dividend of $4.08, EOG’s yield stands at 3.7%.
Siebert Williams Shank expert Gabriele Sorbara declared a buy ranking on EOG stock with a cost target of $150. The stock likewise ratings an “outperform” ranking from TipRanks’ AI Expert, with a cost target of $127.
Sorbara views EOG as a “premier” large-cap business with the capability to browse through product cycles, supported by its strong balance sheet and strong stock. The expert likewise kept in mind the business’s huge totally free money flow-generating abilities.
Especially, Sorbara highlighted EOG’s dedication to return a minimum of 70% of its totally free capital to investors each year through dividends and share buybacks. In reality, the energy business has the versatility to return 100% of totally free capital based upon its balance sheet strength.
The 5-star expert likewise kept in mind EOG’s efforts to utilize advanced innovation to catch additional chances in the Delaware Basin, with the business now recognizing more than 9 various advancement targets. To name a few positives, Sorbara likewise pointed out that EOG is tracking ahead of its target for the very first year with regard to the $150 million synergies from its Encino acquisition. More cost savings are anticipated from aspects like enhanced facilities, production performance, and marketing offers through EOG’s midstream network.
Sorbara ranks No. 225 amongst more than 10,100 experts tracked by TipRanks. His scores have actually achieved success 61% of the time, providing a typical return of 18.4%. See EOG Resources Ownership Structure on TipRanks.
CVS Health
Lastly, let’s take a look at drug store chain CVS Health ( CVS). The business’s turn-around efforts are assisting it drive enhanced efficiency in a tough company background. At its Financier Day occasion on December 9, CVS Health supplied favorable updates and mentioned that it anticipates to attain a mid-teens adjusted revenues per share (EPS) substance yearly development rate (CAGR) through 2028. At a quarterly dividend of $0.665 per share (annualized dividend of $2.66 per share), CVS stock uses a yield of 3.4%.
Following Financier Day, Mizuho expert Ann Hynes repeated a Buy ranking on CVS stock and raised her rate target to $95 from $88. “CVS is our leading choice in our protection universe,” stated the 5-star expert, and pointed out structural enhancement in retail revenues projection as the factor for her modified rate target. Surprisingly, TipRanks’ AI Expert has a “neutral” ranking on CVS with a cost target of $81.
Hynes kept in mind that CVS’ mid-teens changed EPS CAGR target does not consider any extra share buybacks, which she anticipates to occur when the business attains its utilize targets, perhaps by the end of next year.
The expert likewise highlighted the business’s efforts to enhance margins of the Health care Advantages (HCB) sector, which has actually been under pressure due to an ongoing increase in the medical loss ratio (MLR). This ratio is anticipated to decrease by about 50 basis points in 2026 due to much better prices, lowered advantages under Medicare Benefit (MA) strategies, and the business’s choice to leave the Medical insurance Exchange (HIX) company.
Hynes likewise kept in mind the enhancement in CVS’ Drug Store and Customer Health (PCW) sector outlook, with the business now anticipating flat changed operating earnings development compared to the previous assistance of a mid-single-digit decrease. This enhancement is driven by market share gains, a much better repayment background, and expense savings.
Hynes ranks No. 733 amongst more than 10,100 experts tracked by TipRanks. Her scores have actually achieved success 60% of the time, providing a typical return of 8.5%. See CVS Health Options Activity on TipRanks.